Does RITUXIMAB-PVVR Cause Lung neoplasm malignant? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Lung neoplasm malignant have been filed in association with RITUXIMAB-PVVR. This represents 0.3% of all adverse event reports for RITUXIMAB-PVVR.
13
Reports of Lung neoplasm malignant with RITUXIMAB-PVVR
0.3%
of all RITUXIMAB-PVVR reports
4
Deaths
3
Hospitalizations
How Dangerous Is Lung neoplasm malignant From RITUXIMAB-PVVR?
Of the 13 reports, 4 (30.8%) resulted in death, 3 (23.1%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-PVVR Cause?
Off label use (2,079)
Intentional product use issue (627)
Condition aggravated (514)
Death (338)
Covid-19 (322)
Fatigue (318)
Dyspnoea (314)
Inappropriate schedule of product administration (311)
Headache (291)
Pruritus (288)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which RITUXIMAB-PVVR Alternatives Have Lower Lung neoplasm malignant Risk?
RITUXIMAB-PVVR vs RIVAROXABAN
RITUXIMAB-PVVR vs RIVASTIGMINE
RITUXIMAB-PVVR vs RIVOTRIL
RITUXIMAB-PVVR vs RIZATRIPTAN
RITUXIMAB-PVVR vs ROACTEMRA